NCT06879782View on ClinicalTrials.gov

Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

820

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

March 28, 2026

Study Completion Date

September 28, 2026

Conditions
Dry Eye Disease (DED)
Interventions
DRUG

Drug placebo

Instill one drop of the eye solution in each eye, twice a day (morning and evening, approximately 12 hours apart), for a treatment period of 12 weeks.

Trial Locations (1)

100000

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

Beijing Tongren Hospital

OTHER

lead

Lunan Better Pharmaceutical Co., LTD.

INDUSTRY